Literature DB >> 10372023

Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair.

S Arumugam1, Y C Jang, C Chen-Jensen, N S Gibran, F F Isik.   

Abstract

BACKGROUND: Response to tissue injury begins with the deposition of a fibrin-rich clot or the provisional matrix. The provisional matrix consists of plasma-borne matrix molecules that serve as scaffolding for the ensuing migration of cells. During wound repair multiple cell types must migrate through the clot-matrix scaffolding. The migration of these cells through the matrix is dependent on the activity of the fibrinolytic and proteolytic systems, which include the plasminogen activator (PA) system and matrix metalloproteinases (MMP). The aim of this study was to better understand the temporal activity of these enzymes during normal wound repair.
METHODS: We used the murine excisional wound model and extracted proteins under nonreducing conditions. With use of gelatin and casein zymography, we determined the activity of the MMPs during the course of wound repair. In addition, we quantified the activity of MMP-2 and MMP-9 by a standardized assay. Plasminogen zymograms were used to detect urokinase PA and tissue PA activity. Western blots were used to detect the natural inhibitor of PAs, plasminogen activator inhibitor type 1.
RESULTS: Our results demonstrate the temporal activity of MMP-2, MMP-3, MMP-7, and MMP-9 during the course of normal dermal repair. The activity of urokinase PA and tissue PA were also determined; it preceded the activity of the MMPs.
CONCLUSIONS: We demonstrate the temporal activity of the 2 protease families, MMPs and PAs, in the normal process of cutaneous wound healing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10372023

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.

Authors:  Andreea M Bujor; Sashidar Nakerakanti; Erin Morris; Faye N Hant; Maria Trojanowska
Journal:  Exp Dermatol       Date:  2010-02-25       Impact factor: 3.960

Review 3.  Contribution of platelets, the coagulation and fibrinolytic systems to cutaneous wound healing.

Authors:  Aman Opneja; Sargam Kapoor; Evi X Stavrou
Journal:  Thromb Res       Date:  2019-05-02       Impact factor: 3.944

4.  Studies on mRNA expression of tissue-type plasminogen activator in bruises for wound age estimation.

Authors:  Masataka Takamiya; Kiyoshi Saigusa; Reiko Kumagai; Nori Nakayashiki; Yasuhiro Aoki
Journal:  Int J Legal Med       Date:  2004-06-17       Impact factor: 2.686

5.  Analysis of c-myc, PAI-1 and uPAR in patients with incisional hernias.

Authors:  R Rosch; M Binnebösel; K Junge; P Lynen-Jansen; P R Mertens; U Klinge; V Schumpelick
Journal:  Hernia       Date:  2007-12-04       Impact factor: 4.739

6.  TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP.

Authors:  Y P Han; T L Tuan; H Wu; M Hughes; W L Garner
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

7.  Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.

Authors:  Alexandra Fullár; József Dudás; Lászlóné Oláh; Péter Hollósi; Zoltán Papp; Gábor Sobel; Katalin Karászi; Sándor Paku; Kornélia Baghy; Ilona Kovalszky
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

8.  Mechanoresponsive regulation of fibroblast-to-myofibroblast transition in three-dimensional tissue analogues: mechanical strain amplitude dependency of fibrosis.

Authors:  Diego Jacho; Agustin Rabino; Rafael Garcia-Mata; Eda Yildirim-Ayan
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

9.  Gender affects skin wound healing in plasminogen deficient mice.

Authors:  Birgitte Rønø; Lars Henning Engelholm; Leif Røge Lund; Andreas Hald
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.